Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4772070

COc1cc2ccccc2cc1C(=O)Nc1ccc2c(c1)CCN(C1CCC1)CC2.O=C(O)C(F)(F)F

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 10/20 0.50
RAB9A P51151 7/20 0.50
NPC1 O15118 6/20 0.50
TP53 P04637 1/20 0.50
MAPT P10636 1/20 0.50
TSHR P16473 1/20 0.50
MAPK1 P28482 1/20 0.50
MEN1 O00255 8/20 0.48
HCRTR1 O43613 1/20 0.48
POLB P06746 3/20 0.48
AHR P35869 2/20 0.48
APOBEC3A P31941 1/20 0.45
RAD52 P43351 1/20 0.45
APOBEC3G Q9HC16 1/20 0.45
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
HTT P42858 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4771157 0.94 KMT2A (0.56) KMT2ARAB9ANPC1TP53MAPT
Trifluoroacetic Acid SCHEMBL4770456 0.90 NPC1 (0.52) KMT2ARAB9ANPC1TP53MAPT
Trifluoroacetic Acid SCHEMBL4770314 0.84 HRH3 (0.52) KMT2ARAB9ANPC1TP53MAPT
Trifluoroacetic Acid SCHEMBL4772033 0.84 MEN1 (0.44) KMT2ANPC1MAPTMEN1LMNA
Trifluoroacetic Acid SCHEMBL4774158 0.84 TMPRSS2 (0.55) KMT2ARAB9ANPC1TP53MAPT
SCHEMBL4768212 0.83 NPC1 (0.58) KMT2ARAB9ANPC1TP53MAPT
Trifluoroacetic Acid SCHEMBL4767916 0.83 TMPRSS2 (0.55) KMT2ARAB9ANPC1TP53MAPT
Trifluoroacetic Acid SCHEMBL4767946 0.83 HRH3 (0.56) KMT2ARAB9ANPC1TP53MAPT
Trifluoroacetic Acid SCHEMBL4770822 0.82 RAB9A (0.53) KMT2ARAB9ANPC1TP53MAPT
Trifluoroacetic Acid SCHEMBL4765765 0.82 TP53 (0.50) KMT2ARAB9ANPC1TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1713778-B1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LTD (GB) 2008-01-16 EP claimed
US-20070060566-A1 Benzazepine derivatives as histamine h3 antagonists GLAXO GROUP LIMITED (GB) 2007-03-15 US claimed
EP-1713778-B1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LTD (GB) 2008-01-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060566-A1 Benzazepine derivatives as histamine h3 antagonists HRH3, HRH4, HRH1 KMT2A 99/4885RAB9A 2307/4885NPC1 2009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.